Palisade Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.93 | -$2.93 | -$2.93 |
| Q2 2024 | 1 | -$3.35 | -$3.35 | -$3.35 |
| Q3 2024 | 2 | -$2.32 | -$2.00 | -$2.16 |
Palisade Bio, Inc. Earnings Date And Information
Palisade Bio, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-2.32 earnings per share for the quarter, topping analysts' consensus estimates of $-3.35 by $1.03. The company had revenue of 0 for the quarter and had revenue of 250,000 for the year. Palisade Bio, Inc. has generated $-27 earnings per share over the last year ($-27.01 diluted earnings per share) and currently has a price-to-earnings ratio of -0.26. Palisade Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based on prior year's report dates.
Palisade Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$3.35 | -$2.32 | 1.03 | $0 | $0 |
| 08/12/2024 | Q2 2024 | -$2.93 | -$3.32 | -0.39 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$4.80 | -$4.19 | 0.61 | $0 | |
| 03/26/2024 | Q4 2023 | -$5.17 | -$4.81 | 0.36 | $-250,000 | |
| 11/09/2023 | Q3 2023 | -$0.39 | -$7.35 | -6.96 | $0 | |
| 08/10/2023 | Q2 2023 | -$7.95 | $0 | |||
| 05/11/2023 | Q1 2023 | -$7.48 | $250,000 | |||
| 03/22/2023 | Q4 2022 | -$2.43 | -$22.34 | -19.91 | $0 | |
| 11/14/2022 | Q3 2022 | -$4.00 | -$61.45 | -57.45 | $0 | |
| 08/15/2022 | Q2 2022 | -$8.50 | -$86.62 | -78.12 | $0 | |
| 05/13/2022 | Q1 2022 | -$181.91 | -$194.39 | -12.48 | $0 | |
| 03/17/2022 | Q4 2021 | $59.47 | $0 | |||
| 11/12/2021 | Q3 2021 | $317.22 | $0 | |||
| 08/23/2021 | Q2 2021 | -$2,443.91 | $0 | |||
| 05/14/2021 | Q1 2021 | -$72.63 | $0 | |||
| 03/22/2021 | Q4 2020 | -$12.26 | $2,500 | |||
| 11/10/2020 | Q3 2020 | -$33.21 | $2,500 | |||
| 08/13/2020 | Q2 2020 | -$33.50 | $2,500 | |||
| 05/15/2020 | Q1 2020 | -$17.52 | $6,020 | |||
| 03/27/2020 | Q4 2019 | -$21.01 | $2,500 |
Palisade Bio, Inc. Earnings: Frequently Asked Questions
-
When is Palisade Bio, Inc.'s earnings date?
Palisade Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based off last year's report dates.
-
Did Palisade Bio, Inc. beat their earnings estimates last quarter?
In the previous quarter, Palisade Bio, Inc. (:PALI) reported $-2.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.35 by $1.03.
-
How can I listen to Palisade Bio, Inc.'s earnings conference call?
The conference call for Palisade Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Palisade Bio, Inc.'s conference call transcript?
The conference call transcript for Palisade Bio, Inc.'s latest earnings report can be read online.
-
How much revenue does Palisade Bio, Inc. generate each year?
Palisade Bio, Inc. (:PALI) has a recorded annual revenue of $250,000.
-
How much profit does Palisade Bio, Inc. generate each year?
Palisade Bio, Inc. (:PALI) has a recorded net income of $250,000. Palisade Bio, Inc. has generated $-27.01 earnings per share over the last four quarters.
-
What is Palisade Bio, Inc.'s price-to-earnings ratio?
Palisade Bio, Inc. (:PALI) has a price-to-earnings ratio of -0.26 and price/earnings-to-growth ratio is -0.01.
